OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I study of domatinostat (4 SC ‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies

HTML

Year: 2019
Type: article
Study design: Clinical Trial
Source: European Journal Of Haematology
DOI: 10.1111/ejh.13188
Authors: Bastian von Tresckow, Cyrus Sayehli, Walter E. Aulitzky, Maria‐Elisabeth Goebeler, Matthias Schwab, Eunice Braz, Babett Krauss, Rolf Krauss, Frank Hermann, René Bartz, Andreas Engert
Institutions: University Hospital Cologne, Comprehensive Cancer Center Mainfranken, Robert Bosch Hospital, Universitätsklinikum Tübingen, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, University of Tübingen, 4SC (Germany)
Language: English

Topic: Histone Deacetylase Inhibitors Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: class I histone deacetylase inhibitors, dose-limiting toxicity, hypercalcemia, pharmacokinetics, pharmacodynamics, anticancer activity, treatment-related adverse events, maximum tolerated dose, dosing regimen
SDG: Good health and well-being

Open Access status: closed

Funder: Robert Bosch Stiftung
OpenAlex ID: W2896604147
FWCI: 2.341
Cites: 29
Cited by: 57
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security